Over 800,000 lung cancer patients in China by 2020

Published On 2015-12-02 05:29 GMT   |   Update On 2015-12-02 05:29 GMT

Beijing: China is expected to have over 800,000 lung cancer patients diagnosed annually by 2020, with nearly 700,000 people dying from the disease each year, a media report said on Tuesday.Lung cancer has been a growing problem in China since 2000 due to risk factors such as an ageing population, air pollution and excessive smoking, the China Daily reported."The rapid increase of the disease...

Login or Register to read the full article
Beijing: China is expected to have over 800,000 lung cancer patients diagnosed annually by 2020, with nearly 700,000 people dying from the disease each year, a media report said on Tuesday.

Lung cancer has been a growing problem in China since 2000 due to risk factors such as an ageing population, air pollution and excessive smoking, the China Daily reported.

"The rapid increase of the disease will last for at least 20 years," said Zhi Xiuyi, head of the Lung Cancer Diagnosis and Treatment Centre of Capital Medical University, Beijing.

Zhong Nanshan, a respiratory expert and academic at the Chinese Academy of Engineering, expects that PM2.5, a major cause of smog, will replace smoking as the top risk factor for lung cancer.

Currently, lung cancer is the top killer among all other cancer variants, causing about 600,000 deaths per year in China. In 2015, roughly 700,000 people were diagnosed in the country.

In response, the Chinese government has launched health initiatives, including efforts to cut down smoking. But the emerging challenge from the smog "should be addressed as well", Zhi said.

According to the National Health and Family Planning Commission, a nationwide network monitoring the impact of air pollution on human health is underway.

More than 40 monitoring sites will be set up in 16 provinces and municipalities that are frequently engulfed by smog to support research on air pollutants in different regions.
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News